ARCHIVES

ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer

This article is from The Cancer Letter archive.

Vol. 24 No. 22 | June 5, 1998

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves $17 Million In Recompetition; Asks Some Be Switched To Cooperative Agreements

November 23, 1979

NCI Programs: Director Challenges Scientists To Develop Molecular “Fingerprints” Of Tumors

December 4, 1998

NCAB Members Urge More Action In Support Of NCI.

December 15, 2006

ASCO Annual Meeting Abstracts Posted Online

May 28, 2010

NCI News Roundup: clinical Trials Initiatives Explained in Lectures Available Online

June 11, 1999

Phase III Vaccine Trial Fails To Improve Overall Survival

October 25, 2013